placeholder image
T. E. Craven All authors
About
Publications While At Healthpartners
selected publications
Journal Article
  • Longitudinal changes in dietary fat intake and associated changes in cardiovascular risk factors in adults with type 2 diabetes: the ACCORD trial. 
    Diabetes Research and Clinical Practice. 2013
  • Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients. 
    Kidney International. 2012
  • Fenofibrate-associated changes in renal function and relationship to clinical outcomes among individuals with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) experience. 
    Diabetologia. 2012
  • Reversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participants. 
    Diabetes care. 2012
  • Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. 
    Lancet (London, England). 2010
  • Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. 
    Lancet (London, England). 2010
  • The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. 
    BMJ (Clinical research ed.). 2010
  • The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. 
    BMJ (Clinical research ed.). 2010
  • Restricted-carbohydrate diets in patients with type 2 diabetes: a meta-analysis. 
    Journal of the American Dietetic Association. 2008
    • Abstract
  • Microvascular effects of intensive blood pressure control and its relation to glycaemic control in the ACCORD blood pressure trial [abstract]. 
    Diabetologia. 2011
  • Reversibility of fenofibrate-induced renal function impairment in ACCORD type 2 diabetic participants [abstract]. 
    Diabetes. 2011
    • presentations
    Contact
    full name
  • T. E. Craven
    • Quick Info
     
    Collaboration